Related Experiment Video

Updated: Mar 30, 2026

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
11:50

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit

Published on: January 7, 2020

28.2K

Caffeine therapy in preterm infants

Hesham Abdel-Hady1, Nehad Nasef1, Abd Elazeez Shabaan1

  • 1Hesham Abdel-Hady, Nehad Nasef, Abd Elazeez Shabaan, Islam Nour, Neonatal Intensive Care Unit, Mansoura University Children's Hospital, Mansoura 35516, Egypt.

World Journal of Clinical Pediatrics
|November 14, 2015
PubMed

Insights

Caffeine citrate effectively treats apnea of prematurity in preterm infants, reducing breathing pauses and improving outcomes. This review summarizes evidence for optimal caffeine therapy practices in neonatal intensive care units.

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Respiratory Medicine

Background:

  • Caffeine citrate is the primary treatment for apnea of prematurity.
  • It is proven to reduce apnea frequency, hypoxemia, and extubation failure in preterm infants.
  • Potential benefits include reduced incidence of bronchopulmonary dysplasia and patent ductus arteriosus.

Purpose of the Study:

  • To review current evidence on caffeine therapy for preterm infants.
  • To address controversies regarding its use in neonatal intensive care units.
  • To provide guidance on best practices for caffeine administration.

Main Methods:

  • Literature review of studies on caffeine therapy in preterm infants.
  • Analysis of evidence regarding efficacy, safety, and optimal dosing.
  • Synthesis of data to inform clinical practice guidelines.

Main Results:

  • Caffeine citrate is effective in managing apnea of prematurity.
  • Established benefits include reduced respiratory events and improved ventilation outcomes.
  • Ongoing debates exist regarding optimal dosage, duration, and monitoring.

Conclusions:

  • Caffeine citrate is a cornerstone therapy for preterm infants with apnea.
  • Further research and consensus are needed to resolve controversies in its clinical application.
  • Optimizing caffeine therapy can improve short-term outcomes for vulnerable preterm infants.

Keywords:
ApneaCaffeineMethylxanthinesPreterm

More Related Videos

Preterm EEG: A Multimodal Neurophysiological Protocol19:32

Preterm EEG: A Multimodal Neurophysiological Protocol

Published on: February 18, 2012

29.2K
Application of an Amplitude-integrated EEG Monitor Cerebral Function Monitor to Neonates05:58

Application of an Amplitude-integrated EEG Monitor Cerebral Function Monitor to Neonates

Published on: September 6, 2017

41.1K

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
744
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330